LTR Pharma (ASX:LTP) Scaled Net Operating Assets : 0.15 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LTR Pharma's operating assets for the quarter that ended in Jun. 2023 was A$0.37 Mil. LTR Pharma's operating liabilities for the quarter that ended in Jun. 2023 was A$0.02 Mil. LTR Pharma's Total Assets for the quarter that ended in Jun. 2022 was A$2.25 Mil. Therefore, LTR Pharma's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was 0.15.

LTR Pharma Scaled Net Operating Assets Historical Data

The historical data trend for LTR Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Scaled Net Operating Assets Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Scaled Net Operating Assets

0.41

-0.34

0.15

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Scaled Net Operating Assets	0.41	-0.34	0.15

Competitive Comparison of LTR Pharma's Scaled Net Operating Assets

For the Biotechnology subindustry, LTR Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Scaled Net Operating Assets falls into.

LTR Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

LTR Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2023 )
=	(Operating Assets (A: Jun. 2023 )	-	Operating Liabilities (A: Jun. 2023 ))	/	Total Assets (A: Jun. 2022 )
=	(0.365	-	0.021)	/	2.245
=	0.15

where

	Operating Assets		(A: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	7.51	-	7.145
=	0.365

	Operating Liabilities		(A: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.021	-	0	-	0
=	0.021

LTR Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Jun. 2022 )
=	(0.365	-	0.021)	/	2.245
=	0.15

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	7.51	-	7.145
=	0.365

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.021	-	0	-	0
=	0.021

LTR Pharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines